{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:56:17Z","timestamp":1776761777962,"version":"3.51.2"},"reference-count":57,"publisher":"Zhejiang University Press","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1631\/jzus.b2200116","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T03:02:37Z","timestamp":1668999757000},"page":"915-930","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells","\u4f18\u5316\u7684TTF-1\u6838\u5fc3\u542f\u52a8\u5b50\u9a71\u52a8miRNA-7\u8868\u8fbe\u6709\u6548\u6291\u5236\u4eba\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u7ec6\u80de\u7684\u751f\u957f"],"prefix":"10.1631","volume":"23","author":[{"given":"Shipeng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengmeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanjuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2943-9220","authenticated-orcid":false,"given":"Ya","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4497-6083","authenticated-orcid":false,"given":"Yong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6889-0279","authenticated-orcid":false,"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"635","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"issue":"2","key":"648_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s41061-017-0128-5","volume":"375","author":"N Amreddy","year":"2017","unstructured":"Amreddy N, Babu A, Muralidharan R, et al., 2017. Polymeric nanoparticle-mediated gene delivery for lung cancer treatment. Top Curr Chem (Cham), 375(2):35. https:\/\/doi.org\/10.1007\/s41061-017-0128-5","journal-title":"Top Curr Chem (Cham)"},{"key":"648_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ctrv.2016.10.001","volume":"51","author":"C Billiet","year":"2016","unstructured":"Billiet C, Peeters S, Decaluw\u00e9 H, et al., 2016. Postoperative radiotherapy for lung cancer: is it worth the controversy? Cancer Treat Rev, 51:10\u201318. https:\/\/doi.org\/10.1016\/j.ctrv.2016.10.001","journal-title":"Cancer Treat Rev"},{"key":"648_CR3","doi-asserted-by":"publisher","first-page":"100915","DOI":"10.1016\/j.preteyeres.2020.100915","volume":"83","author":"K Bucher","year":"2021","unstructured":"Bucher K, Rodr\u00edguez-Bocanegra E, Dauletbekov D, et al., 2021. Immune responses to retinal gene therapy using adeno-associated viral vectors-implications for treatment success and safety. Prog Retin Eye Res, 83:100915. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100915","journal-title":"Prog Retin Eye Res"},{"issue":"47","key":"648_CR4","doi-asserted-by":"publisher","first-page":"77468","DOI":"10.18632\/oncotarget.12684","volume":"7","author":"Q Cao","year":"2016","unstructured":"Cao Q, Mao ZD, Shi YJ, et al., 2016. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK\/MAPK signaling pathway. Oncotarget, 7(47):77468\u201377481. https:\/\/doi.org\/10.18632\/oncotarget.12684","journal-title":"Oncotarget"},{"issue":"S5","key":"648_CR5","doi-asserted-by":"publisher","first-page":"S565","DOI":"10.3978\/j.issn.2072-1439.2013.07.43","volume":"5","author":"BA Chan","year":"2013","unstructured":"Chan BA, Coward JIG, 2013. Chemotherapy advances in small-cell lung cancer. J Thorac Dis, 5(S5):S565\u2013S578. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2013.07.43","journal-title":"J Thorac Dis"},{"issue":"6","key":"648_CR6","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/hep.31570","volume":"73","author":"RJ Chandler","year":"2021","unstructured":"Chandler RJ, Venturoni LE, Liao J, et al., 2021. Promoterless, nuclease-free genome editing confers a growth advantage for corrected hepatocytes in mice with methylmalonic acidemia. Hepatology, 73(6):2223\u20132237. https:\/\/doi.org\/10.1002\/hep.31570","journal-title":"Hepatology"},{"issue":"1","key":"648_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/imm.13252","volume":"162","author":"HZ Chen","year":"2021","unstructured":"Chen HZ, Guo MM, Yue DX, et al., 2021. MicroRNA-7 negatively regulates Toll-like receptor 4 signaling pathway through FAM177A. Immunology, 162(1):44\u201357. https:\/\/doi.org\/10.1111\/imm.13252","journal-title":"Immunology"},{"issue":"18","key":"648_CR8","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.3390\/cells11182852","volume":"11","author":"SP Chen","year":"2022","unstructured":"Chen SP, Wang Y, Li DM, et al., 2022. Mechanisms controlling microRNA expression in tumor. Cells, 11(18):2852. https:\/\/doi.org\/10.3390\/cells11182852","journal-title":"Cells"},{"issue":"8","key":"648_CR9","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.bbagrm.2015.04.003","volume":"1849","author":"YM Danino","year":"2015","unstructured":"Danino YM, Even D, Ideses D, et al., 2015. The core promoter: at the heart of gene expression. Biochim Biophys Acta, 1849(8):1116\u20131131. https:\/\/doi.org\/10.1016\/j.bbagrm.2015.04.003","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"648_CR10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1631\/jzus.B2000802","volume":"22","author":"X Du","year":"2021","unstructured":"Du X, Xiao JJ, Fu XF, et al., 2021. A proteomic analysis of Bcl-2 regulation of cell cycle arrest: insight into the mechanisms. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(10):839\u2013855. https:\/\/doi.org\/10.1631\/jzus.B2000802","journal-title":"J Zhejiang Univ-Sci B (Biomed & Biotechnol)"},{"issue":"4","key":"648_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1631\/jzus.B2100748","volume":"23","author":"X Du","year":"2022","unstructured":"Du X, Zhang JQ, Liu L, et al., 2022. A novel anticancer property of Lycium barbarum polysaccharide in triggering ferroptosis of breast cancer cells. J Zhejiang Univ-Sci B (Biomed& Biotechnol), 23(4):286\u2013299. https:\/\/doi.org\/10.1631\/jzus.B2100748","journal-title":"J Zhejiang Univ-Sci B (Biomed& Biotechnol)"},{"issue":"11","key":"648_CR12","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1200\/JCO.20.03025","volume":"39","author":"R Dziadziuszko","year":"2021","unstructured":"Dziadziuszko R, Krebs MG, de Braud F, et al., 2021. Updated integrated analysis of the efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small-cell lung cancer. J Clin Oncol, 39(11):1253\u20131263. https:\/\/doi.org\/10.1200\/JCO.20.03025","journal-title":"J Clin Oncol"},{"key":"648_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-4939-7223-4_7","volume-title":"Mammalian Synthetic Promoters","author":"DY Even","year":"2017","unstructured":"Even DY, Kedmi A, Ideses D, et al., 2017. Functional screening of core promoter activity. In: Gould D (Ed.), Mammalian Synthetic Promoters. Humana, New York, p.77\u201391. https:\/\/doi.org\/10.1007\/978-1-4939-7223-4_7"},{"issue":"1","key":"648_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1158\/1535-7163.MCT-06-0408","volume":"6","author":"T Fukazawa","year":"2007","unstructured":"Fukazawa T, Maeda Y, Durbin ML, et al., 2007. Pulmonary adenocarcinoma-targeted gene therapy by a cancer- and tissue-specific promoter system. Mol Cancer Ther, 6(1): 244\u2013252. https:\/\/doi.org\/10.1158\/1535-7163.MCT-06-0408","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"648_CR15","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1007\/s11095-006-9074-6","volume":"23","author":"SV Fulzele","year":"2006","unstructured":"Fulzele SV, Chatterjee A, Shaik MS, et al., 2006. Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model. Pharm Res, 23(9):2094\u20132106. https:\/\/doi.org\/10.1007\/s11095-006-9074-6","journal-title":"Pharm Res"},{"key":"648_CR16","doi-asserted-by":"publisher","first-page":"9957209","DOI":"10.1155\/2021\/9957209","volume":"2021","author":"L Guan","year":"2021","unstructured":"Guan L, Zhao X, Tang L, et al., 2021. Thyroid transcription factor-1: structure, expression, function and its relationship with disease. Biomed Res Int, 2021:9957209. https:\/\/doi.org\/10.1155\/2021\/9957209","journal-title":"Biomed Res Int"},{"issue":"5","key":"648_CR17","doi-asserted-by":"publisher","first-page":"7086","DOI":"10.3892\/mmr.2017.7490","volume":"16","author":"QM Huang","year":"2017","unstructured":"Huang QM, Zeng YM, Lin HH, et al., 2017. Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of non-small cell lung cancer cells. Mol Med Rep, 16(5):7086\u20137091. https:\/\/doi.org\/10.3892\/mmr.2017.7490","journal-title":"Mol Med Rep"},{"issue":"7","key":"648_CR18","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1128\/MCB.16.7.3626","volume":"16","author":"K Ikeda","year":"1996","unstructured":"Ikeda K, Shaw-White JR, Wert SE, et al., 1996. Hepatocyte nuclear factor 3 activates transcription of thyroid transcription factor 1 in respiratory epithelial cells. Mol Cell Biol, 16(7):3626\u20133636. https:\/\/doi.org\/10.1128\/MCB.16.7.3626","journal-title":"Mol Cell Biol"},{"issue":"22","key":"648_CR19","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.7150\/jca.26830","volume":"9","author":"JH Kim","year":"2018","unstructured":"Kim JH, Kim HS, Kim BJ, et al., 2018. Prognostic impact of TTF-1 expression in non-squamous non-small-cell lung cancer: a meta-analysis. J Cancer, 9(22):4279\u20134286. https:\/\/doi.org\/10.7150\/jca.26830","journal-title":"J Cancer"},{"issue":"4","key":"648_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/gt.2012.47","volume":"20","author":"K Kizzire","year":"2013","unstructured":"Kizzire K, Khargharia S, Rice KG, 2013. High-affinity PEGylated polyacridine peptide polyplexes mediate potent in vivo gene expression. Gene Ther, 20(4):407\u2013416. https:\/\/doi.org\/10.1038\/gt.2012.47","journal-title":"Gene Ther"},{"issue":"1\u20132","key":"648_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1615\/CritRevOncog.2016016084","volume":"21","author":"H Lara-Guerra","year":"2016","unstructured":"Lara-Guerra H, Roth JA, 2016. Gene therapy for lung cancer. Crit Rev Oncog, 21(1\u20132):115\u2013124. https:\/\/doi.org\/10.1615\/CritRevOncog.2016016084","journal-title":"Crit Rev Oncog"},{"issue":"7","key":"648_CR22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/17425247.2019.1641083","volume":"16","author":"AY Lee","year":"2019","unstructured":"Lee AY, Cho MH, Kim S, 2019. Recent advances in aerosol gene delivery systems using non-viral vectors for lung cancer therapy. Expert Opin Drug Deliv, 16(7):757\u2013772. https:\/\/doi.org\/10.1080\/17425247.2019.1641083","journal-title":"Expert Opin Drug Deliv"},{"key":"648_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.omtn.2016.12.005","volume":"6","author":"LY Lei","year":"2017","unstructured":"Lei LY, Chen C, Zhao JJ, et al., 2017. Targeted expression of miR-7 operated by TTF-1 promoter inhibited the growth of human lung cancer through the NDUFA4 pathway. Mol Ther Nucleic Acids, 6:183\u2013197. https:\/\/doi.org\/10.1016\/j.omtn.2016.12.005","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"648_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3727\/096504015X14386062091352","volume":"22","author":"C Li","year":"2014","unstructured":"Li C, Wu X, Zhang W, et al., 2014. AEG-1 promotes metastasis through downstream AKR1C2 and NF1 in liver cancer. Oncol Res, 22(4):203\u2013211. https:\/\/doi.org\/10.3727\/096504015X14386062091352","journal-title":"Oncol Res"},{"issue":"4","key":"648_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1631\/jzus.B2100009","volume":"22","author":"C Li","year":"2021","unstructured":"Li C, Brant E, Budak H, et al., 2021. CRISPR\/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement. J Zhejiang Univ-Sci B (Biomed&Biotechnol), 22(4):253\u2013284. https:\/\/doi.org\/10.1631\/jzus.B2100009","journal-title":"J Zhejiang Univ-Sci B (Biomed&Biotechnol)"},{"issue":"6","key":"648_CR26","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.3892\/or.2014.3519","volume":"32","author":"JR Li","year":"2014","unstructured":"Li JR, Zheng YJ, Sun GY, et al., 2014. Restoration of miR-7 expression suppresses the growth of Lewis lung cancer cells by modulating epidermal growth factor receptor signaling. Oncol Rep, 32(6):2511\u20132516. https:\/\/doi.org\/10.3892\/or.2014.3519","journal-title":"Oncol Rep"},{"issue":"9","key":"648_CR27","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1089\/scd.2012.0620","volume":"22","author":"Y Li","year":"2013","unstructured":"Li Y, Eggermont K, Vanslembrouck V, et al., 2013. NKX2-1 activation by SMAD2 signaling after definitive endoderm differentiation in human embryonic stem cell. Stem Cells Dev, 22(9):1433\u20131442. https:\/\/doi.org\/10.1089\/scd.2012.0620","journal-title":"Stem Cells Dev"},{"issue":"12","key":"648_CR28","doi-asserted-by":"publisher","first-page":"e51400","DOI":"10.1371\/journal.pone.0051400","volume":"7","author":"NM Linnerth-Petrik","year":"2012","unstructured":"Linnerth-Petrik NM, Santry LA, Yu DL, et al., 2012. Adeno-associated virus vector mediated expression of an oncogenic retroviral envelope protein induces lung adenocarcinomas in immunocompetent mice. PLoS ONE, 7(12):e51400. https:\/\/doi.org\/10.1371\/journal.pone.0051400","journal-title":"PLoS ONE"},{"issue":"5","key":"648_CR29","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3892\/ijo.2014.2322","volume":"44","author":"ZL Liu","year":"2014","unstructured":"Liu ZL, Jiang ZM, Huang JY, et al., 2014. miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K\/ATK and Raf\/MEK\/ERK pathways. Int J Oncol, 44(5): 1571\u20131580. https:\/\/doi.org\/10.3892\/ijo.2014.2322","journal-title":"Int J Oncol"},{"issue":"5","key":"648_CR30","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.hoc.2017.05.002","volume":"31","author":"CT Lux","year":"2017","unstructured":"Lux CT, Scharenberg AM, 2017. Therapeutic gene editing safety and specificity. Hematol Oncol Clin North Am, 31(5):787\u2013795. https:\/\/doi.org\/10.1016\/j.hoc.2017.05.002","journal-title":"Hematol Oncol Clin North Am"},{"issue":"12","key":"648_CR31","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/hmg\/ddz317","volume":"29","author":"G Massaro","year":"2020","unstructured":"Massaro G, Hughes MP, Whaler SM, et al., 2020. Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes. Hum Mol Genet, 29(12):1933\u20131949. https:\/\/doi.org\/10.1093\/hmg\/ddz317","journal-title":"Hum Mol Genet"},{"issue":"22","key":"648_CR32","doi-asserted-by":"publisher","first-page":"8499","DOI":"10.1128\/MCB.20.22.8499-8512.2000","volume":"20","author":"M Nakazato","year":"2000","unstructured":"Nakazato M, Chung HK, Ulianich L, et al., 2000. Thyroglobulin repression of thyroid transcription factor 1 (TTF-1) gene expression is mediated by decreased DNA binding of nuclear factor I proteins which control constitutive TTF-1 expression. Mol Cell Biol, 20(22):8499\u20138512. https:\/\/doi.org\/10.1128\/MCB.20.22.8499-8512.2000","journal-title":"Mol Cell Biol"},{"issue":"7573","key":"648_CR33","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nature15818","volume":"526","author":"L Naldini","year":"2015","unstructured":"Naldini L, 2015. Gene therapy returns to centre stage. Nature, 526(7573):351\u2013360. https:\/\/doi.org\/10.1038\/nature15818","journal-title":"Nature"},{"issue":"3","key":"648_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.mcna.2018.12.006","volume":"103","author":"F Nasim","year":"2019","unstructured":"Nasim F, Sabath BF, Eapen GA, 2019. Lung cancer. Med Clin North Am, 103(3):463\u2013473. https:\/\/doi.org\/10.1016\/j.mcna.2018.12.006","journal-title":"Med Clin North Am"},{"key":"648_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40246-017-0109-3","volume":"11","author":"C Philpott","year":"2017","unstructured":"Philpott C, Tovell H, Frayling IM, et al., 2017. The NF1 somatic mutational landscape in sporadic human cancers. Hum Genomics, 11:13. https:\/\/doi.org\/10.1186\/s40246-017-0109-3","journal-title":"Hum Genomics"},{"issue":"102","key":"648_CR36","first-page":"49","volume":"19","author":"SK Powell","year":"2015","unstructured":"Powell SK, Rivera-Soto R, Gray SJ, 2015. Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy. Discov Med, 19(102): 49\u201357.","journal-title":"Discov Med"},{"issue":"5","key":"648_CR37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41417-020-00225-0","volume":"28","author":"J Pruller","year":"2021","unstructured":"Pruller J, Hofer I, Ganassi M, et al., 2021. A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy. Cancer Gene Ther, 28(5):427\u2013441. https:\/\/doi.org\/10.1038\/s41417-020-00225-0","journal-title":"Cancer Gene Ther"},{"issue":"18","key":"648_CR38","doi-asserted-by":"publisher","first-page":"5946","DOI":"10.26355\/eurrev_201809_15925","volume":"22","author":"B Qian","year":"2018","unstructured":"Qian B, Wang DM, Gu XS, et al., 2018. LncRNA H19 serves as a ceRNA and participates in non-small cell lung cancer development by regulating microRNA-107. Eur Rev Med Pharmacol Sci, 22(18):5946\u20135953. https:\/\/doi.org\/10.26355\/eurrev_201809_15925","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"648_CR39","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1158\/1535-7163.MCT-11-0220","volume":"10","author":"KM Rai","year":"2011","unstructured":"Rai KM, Takigawa N, Ito S, et al., 2011. Liposomal delivery of microRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells. Mol Cancer Ther, 10(9): 1720\u20131727. https:\/\/doi.org\/10.1158\/1535-7163.MCT-11-0220","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"648_CR40","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/jgm.921","volume":"8","author":"MG Sebesty\u00e9n","year":"2006","unstructured":"Sebesty\u00e9n MG, Budker VG, Budker T, et al., 2006. Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte uptake of various molecules. J Gene Med, 8(7):852\u2013873. https:\/\/doi.org\/10.1002\/jgm.921","journal-title":"J Gene Med"},{"issue":"5","key":"648_CR41","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.ymthe.2021.04.006","volume":"29","author":"S Sheikh","year":"2021","unstructured":"Sheikh S, Ernst D, Keating A, 2021. Prodrugs and prodrug-activated systems in gene therapy. Mol Ther, 29(5): 1716\u20131728. https:\/\/doi.org\/10.1016\/j.ymthe.2021.04.006","journal-title":"Mol Ther"},{"issue":"37","key":"648_CR42","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1038\/onc.2009.187","volume":"28","author":"YP Sher","year":"2009","unstructured":"Sher YP, Tzeng TF, Kan SF, et al., 2009. Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer growth and improves long-term survival. Oncogene, 28(37):3286\u20133295. https:\/\/doi.org\/10.1038\/onc.2009.187","journal-title":"Oncogene"},{"issue":"3","key":"648_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2217\/pgs-2018-0161","volume":"20","author":"JC Su","year":"2019","unstructured":"Su JC, Ruan SL, Dai SK, et al., 2019. NF1 regulates apoptosis in ovarian cancer cells by targeting MCL1 via miR-142-5p. Pharmacogenomics, 20(3): 155\u2013165. https:\/\/doi.org\/10.2217\/pgs-2018-0161","journal-title":"Pharmacogenomics"},{"issue":"1","key":"648_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcb.20851","volume":"99","author":"EM Toloza","year":"2006","unstructured":"Toloza EM, Morse MA, Lyerly HK, 2006. Gene therapy for lung cancer. J Cell Biochem, 99(1):1\u201322. https:\/\/doi.org\/10.1002\/jcb.20851","journal-title":"J Cell Biochem"},{"key":"648_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/postgradmedj-2021-139860","volume":"0","author":"S Umakanthan","year":"2021","unstructured":"Umakanthan S, Bukelo MM, 2021. Concise genetic profile of lung carcinoma. Postgrad Med J, 0:1\u20135. https:\/\/doi.org\/10.1136\/postgradmedj-2021-139860","journal-title":"Postgrad Med J"},{"issue":"6","key":"648_CR46","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.4103\/jcrt.JCRT_187_19","volume":"17","author":"S Umakanthan","year":"2021","unstructured":"Umakanthan S, Rao AVC, Mohammed W, 2021. Role of immunohistochemistry markers in neoplastic lung lesions. J Cancer Res Ther, 17(6):1382\u20131388. https:\/\/doi.org\/10.4103\/jcrt.JCRT_187_19","journal-title":"J Cancer Res Ther"},{"issue":"14","key":"648_CR47","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-10-0655","volume":"70","author":"JF Wiggins","year":"2010","unstructured":"Wiggins JF, Ruffino L, Kelnar K, et al., 2010. Development of a lung cancer therapeutic based on the tumor suppres-sormicroRNA-34. Cancer Res, 70(14):5923\u20135930. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-0655","journal-title":"Cancer Res"},{"key":"648_CR48","doi-asserted-by":"publisher","first-page":"13955","DOI":"10.1038\/s41598-017-14289-w","volume":"7","author":"C Wilson","year":"2017","unstructured":"Wilson C, Nimick M, Nehoff H, et al., 2017. ALK and IGF-1R as independent targets in crizotinib resistant lung cancer. Sci Rep, 7:13955. https:\/\/doi.org\/10.1038\/s41598-017-14289-w","journal-title":"Sci Rep"},{"issue":"8","key":"648_CR49","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1158\/1535-7163.MCT-09-0056","volume":"8","author":"XM Xie","year":"2009","unstructured":"Xie XM, Hsu JL, Choi MG, et al., 2009. A novel hTERT promoter-driven E1A therapeutic for ovarian cancer. Mol Cancer Ther, 8(8):2375\u20132382. https:\/\/doi.org\/10.1158\/1535-7163.MCT-09-0056","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"648_CR50","doi-asserted-by":"publisher","first-page":"805","DOI":"10.7150\/ijbs.7.805","volume":"7","author":"SD Xiong","year":"2011","unstructured":"Xiong SD, Zheng YJ, Jiang P, et al., 2011. MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2. Int J Biol Sci, 7(6):805\u2013814. https:\/\/doi.org\/10.7150\/ijbs.7.805","journal-title":"Int J Biol Sci"},{"issue":"12","key":"648_CR51","doi-asserted-by":"publisher","first-page":"e83097","DOI":"10.1371\/journal.pone.0083097","volume":"8","author":"BY Zhang","year":"2013","unstructured":"Zhang BY, Wang O, Qin JC, et al., 2013. cis-Acting elements and trans-acting factors in the transcriptional regulation of Raf kinase inhibitory protein expression. PLoS ONE, 8(12):e83097. https:\/\/doi.org\/10.1371\/journal.pone.0083097","journal-title":"PLoS ONE"},{"issue":"5","key":"648_CR52","doi-asserted-by":"publisher","first-page":"e1243","DOI":"10.1038\/cddis.2014.201","volume":"5","author":"EB Zhang","year":"2014","unstructured":"Zhang EB, Yin DD, Sun M, et al., 2014. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis, 5(5):e1243. https:\/\/doi.org\/10.1038\/cddis.2014.201","journal-title":"Cell Death Dis"},{"issue":"1","key":"648_CR53","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11684-015-0390-2","volume":"9","author":"R Zhang","year":"2015","unstructured":"Zhang R, Wang Q, Zhang L, et al., 2015. Optimized human factor IX expression cassettes for hepatic-directed gene therapy of hemophilia B. Front Med, 9(1):90\u201399. https:\/\/doi.org\/10.1007\/s11684-015-0390-2","journal-title":"Front Med"},{"issue":"6","key":"648_CR54","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3892\/mco.2015.648","volume":"3","author":"JJ Zhao","year":"2015","unstructured":"Zhao JJ, Wang KL, Liao ZY, et al., 2015. Promoter mutation of tumor suppressor microRNA-7 is associated with poor prognosis of lung cancer. Mol Clin Oncol, 3(6):1329\u20131336. https:\/\/doi.org\/10.3892\/mco.2015.648","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"648_CR55","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/hep.31607","volume":"74","author":"JJ Zhao","year":"2021","unstructured":"Zhao JJ, Chu FY, Xu HL, et al., 2021. C\/EBP\u03b1\/miR-7 controls CD4+ T-cell activation and function and orchestrates experimental autoimmune hepatitis in mice. Hepatology, 74(1):379\u2013396. https:\/\/doi.org\/10.1002\/hep.31607","journal-title":"Hepatology"},{"issue":"1","key":"648_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.20892\/j.issn.2095-3941.2020.0250","volume":"18","author":"X Zhao","year":"2021","unstructured":"Zhao X, Yang J, Huang RY, et al., 2021. The role and its mechanism of intermittent fasting in tumors: friend or foe? Cancer Biol Med, 18(1):63\u201373. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0250","journal-title":"Cancer Biol Med"},{"issue":"6","key":"648_CR57","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1002\/cam4.2183","volume":"8","author":"XB Zhuang","year":"2019","unstructured":"Zhuang XB, Zhao C, Li JY, et al., 2019. Clinical features and therapeutic options in non-small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF. Cancer Med, 8(6):2858\u20132866. https:\/\/doi.org\/10.1002\/cam4.2183","journal-title":"Cancer Med"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2200116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2200116\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2200116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T15:03:43Z","timestamp":1669129423000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2200116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["648"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2200116","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"8 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}